Munich Re
Provides reinsurance and specialty insurance solutions globally, alongside the ERGO brand's direct insurance products for life, health, and property-casualty coverage.
As of Oct 15, 2026
Summary
Munich Re is a German reinsurer offering property, casualty and life reinsurance globally. The stock has a bullish technical bias and has climbed 4.0 percent over the past month, though it remains down 0.9 percent for the year at its current price of €533.40. The company holds a market capitalisation of €67.1 billion.
Price history
As of Oct 14, 2026
Performance
+2.14%
+3.25%
+4.02%
+3.45%
-0.59%
-0.91%
As of Oct 14, 2026
Technical indicators
- 67.3
- 2.95Bullish
- 50: 514.14 · 200: 503.25Bullish
- €511.40 / —
Technical Bias
Bullish lean
Munich Re's technical indicators tilt bullish right now. The MACD is positive at 2.95 and both key moving averages (the 50-day at 514.14 and 200-day at 503.25) sit below the current price of 533.40, suggesting upward momentum. This is a derived technical read, not investment advice.
A transparent read of the indicators below — not a prediction or recommendation.
As of Oct 14, 2026
Fundamentals
- €67.1B
- 9.77
- €54.61
- 11.16%
- +1.3%
- €1.10B
- 0.32
- €437.40 – €546.50
- 4.65%
- Apr 30, 2026
- Nov 12, 2026 (27 days)
As of Oct 16, 2026
Upcoming catalysts
- Earnings report
As of Oct 16, 2026
Latest news
As of Oct 16, 2026
MonkeyTrade's Take on Munich Re
Short-term outlook
Munich Re's short-term setup leans bullish: price sits above both the 50-day (€514.14) and 200-day (€503.25) averages, MACD confirms upward momentum, and the stock is up 4.0% over the past month. RSI at 67.3 is approaching overbought territory, so a pause wouldn't be surprising. The €511.40 support level is the one to watch — holding above it keeps the bullish read intact, while a break would undermine it. No earnings catalyst is imminent, with the next report not due until November 2026.
Medium-term outlook
Munich Re's valuation still looks modest at a 9.77 price-to-earnings ratio, backed by an 11.2% profit margin and a 4.7% dividend yield, even as revenue growth sits at a slim 1.3%. With the technical lean bullish, the balance over the next few quarters tilts constructive, with the stock looking more like a value-and-income holding than a growth story. A marked pickup or further slippage in revenue growth would be the key swing factor for this view.
Key risks
- Revenue growth of just +1.3% year on year suggests underlying business expansion is modest, which could limit earnings momentum if claims or costs rise.
- Large reinsurance deals like the Manulife long-term care transaction shift significant risk onto Munich Re's books, and mispricing long-tail liabilities of this kind can weigh on results years later.
- Trading near the top of its 52-week range at €533.40, against a high of €546.50, leaves less room for error if sentiment turns or catastrophe losses surprise to the upside.
- Increased competition from new entrants such as JAB Institutional's insurance platform could pressure pricing and margins across the reinsurance sector over time.
About Munich Re
Munich Re is one of the world's largest reinsurance groups, based in Germany and listed on XETRA under the ticker MUV2. Operating within the financial services sector, specifically reinsurance, the company works behind the scenes of the insurance industry, helping primary insurers manage large-scale risk. With a market capitalisation of €67.1B, Munich Re stands as a heavyweight in its industry, reflecting its scale and the significant role it plays in global risk management.
The company's key figures give some insight into how the market currently views it. A price-to-earnings ratio of 9.77 suggests shares trade at a relatively modest multiple of earnings, while a dividend yield of +4.7% points to a notable income return for shareholders. Together, these figures sketch a profile of an established, income-generating business within a specialised corner of financial services.
How to trade Munich Re
Shares like this are usually traded as CFDs. Compare regulated brokers that offer share CFDs — weigh spreads, fees and platforms before you open an account.
AI-assisted research for informational purposes only — not investment advice. Figures are sourced from third-party market data and may be delayed. Do your own research before trading. Your capital is at risk. How we build these pages.